Journal of General Internal Medicine

, Volume 22, Issue 4, pp 485–490 | Cite as

Long-Term Opioid Contract Use for Chronic Pain Management in Primary Care Practice. A Five Year Experience

  • Jaishree Hariharan
  • Geoffrey C. Lamb
  • Joan M. Neuner
Original Article

Background

The use of opioid medications to manage chronic pain is complex and challenging, especially in primary care settings. Medication contracts are increasingly being used to monitor patient adherence, but little is known about the long-term outcomes of such contracts.

Objective

To describe the long-term outcomes of a medication contract agreement for patients receiving opioid medications in a primary care setting.

Design

Retrospective cohort study.

Subjects

All patients placed on a contract for opioid medication between 1998 and 2003 in an academic General Internal Medicine teaching clinic.

Measurements

Demographics, diagnoses, opiates prescribed, urine drug screens, and reasons for contract cancellation were recorded. The association of physician contract cancellation with patient factors and medication types were examined using the Chi-square test and multivariate logistic regression.

Results

A total of 330 patients constituting 4% of the clinic population were placed on contracts during the study period. Seventy percent were on indigent care programs. The majority had low back pain (38%) or fibromyalgia (23%). Contracts were discontinued in 37%. Only 17% were cancelled for substance abuse and noncompliance. Twenty percent discontinued contract voluntarily. Urine toxicology screens were obtained in 42% of patients of whom 38% were positive for illicit substances.

Conclusions

Over 60% of patients adhered to the contract agreement for opioids with a median follow-up of 22.5 months. Our experience provides insight into establishing a systematic approach to opioid administration and monitoring in primary care practices. A more structured drug testing strategy is needed to identify nonadherent patients.

Key words

chronic pain contract outcomes 

Notes

Acknowledgement

The Authors wish to thank Chris A. McLaughlin (from the Department of Family Medicine Academic, Medical College of Wisconsin, Milwaukee, Wisconsin) for editorial support.

Potential Financial Conflicts of Interest

None disclosed.

References

  1. 1.
    Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:791–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Guerje O, Von Korff M, Simon GE, Gater R. Persistent pain and well being. A World Health Organization study in primary care. JAMA. 1998;280:147–51.CrossRefGoogle Scholar
  3. 3.
    Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O’Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Chelminski PR, Ives TJ, Felix KM. A primary care, multi-disciplinary pain management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric co-morbidity. BMC Health Serv Res. 2005;5(1):3.PubMedCrossRefGoogle Scholar
  5. 5.
    Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases. Pain. 1986;25:171–86.PubMedCrossRefGoogle Scholar
  6. 6.
    Turk DC. Clinical effectiveness and cost-effectiveness of treatments. Clin J Pain. 2002;18:355–65.PubMedCrossRefGoogle Scholar
  7. 7.
    Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203–17.PubMedCrossRefGoogle Scholar
  8. 8.
    Bendson P, Hensing G, Ebeling C, Schedin A. What are the qualities of dilemmas experienced when prescribing opioids in general practice? Pain. 1999;82:89–96.CrossRefGoogle Scholar
  9. 9.
    Fishman SM, Wilsey B, Yang J, Reisfield GM, Bandman TB, Borsook DB. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage. 2000;20(4):293–307.PubMedCrossRefGoogle Scholar
  10. 10.
    Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943–53.PubMedCrossRefGoogle Scholar
  11. 11.
    Sanders SH, Harden RN, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: an evidence-based approach. J Back Musculoskelet Rehabil. 1999;13:47–58.Google Scholar
  12. 12.
    Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management. Chronic Pain Section. Anesthesiology. 1997;86:995–04.Google Scholar
  13. 13.
    American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement. Clin J Pain. 1997;13:6–8.CrossRefGoogle Scholar
  14. 14.
    Guidelines for the assessment and management of chronic pain. Wisconsin Medical Society Taskforce on Pain Management. WMJ. 2004;103(3):15–42.Google Scholar
  15. 15.
    Donovan MI, Evers K, Jacobs P, Mandleblatt S. When there is no benchmark: designing a primary care-based chronic pain management program from the scientific basis up. J Pain Symptom Manage. 1999;18:38–48.PubMedCrossRefGoogle Scholar
  16. 16.
    Quill TE. Partnerships in patient care: a contractual approach. Ann Intern Med. 1983;98:228–34.PubMedGoogle Scholar
  17. 17.
    Miller LJ. The formal treatment contract in the inpatient management of borderline personality disorder. Hospital and Community Psychiatry. 1990;41:985–7.PubMedGoogle Scholar
  18. 18.
    Hariharan J, Denson KM. A challenging patient, an innovative solution. WMJ. 2005;104(8):72–5.PubMedGoogle Scholar
  19. 19.
    Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999;18(1):27–37.PubMedCrossRefGoogle Scholar
  20. 20.
    Fishman SM, Kreis PG. The opioid contract. Clin J Pain. 2003;18(4)(Supp):S70–S75.Google Scholar
  21. 21.
    Arnold RM, Han PKJ, Seltzer D. Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties. Am J Med. 2006;119(4):292–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Robinson RC, et al. Screening for problematic prescription opioid use. Clin J Pain. 2001;17(3):220–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Chabel C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors (see comments). Clin J Pain. 1997;12:150–5.CrossRefGoogle Scholar
  24. 24.
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.PubMedCrossRefGoogle Scholar
  25. 25.
    Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(4)(suppl):S76–S82.Google Scholar
  26. 26.
    Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Katz NP, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097–102.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2007

Authors and Affiliations

  • Jaishree Hariharan
    • 1
  • Geoffrey C. Lamb
    • 1
  • Joan M. Neuner
    • 1
  1. 1.Division of General Internal MedicineMedical College of WisconsinMilwaukeeUSA

Personalised recommendations